Sodium Palmitate

CAS No. 408-35-5

Sodium Palmitate( —— )

Catalog No. M21839 CAS No. 408-35-5

Sodium palmitate is a common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sodium Palmitate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium palmitate is a common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
  • Description
    Sodium palmitate is a common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids. It is commonly obtained by the saponification of palm oil.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    408-35-5
  • Formula Weight
    278.41
  • Molecular Formula
    C16H31NaO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 8.33 mg/mL (29.92 mM)
  • SMILES
    CCCCCCCCCCCCCCCC(=O)[O-].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cajanin

    Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.

  • Hydroxylamine

    Hydroxylamine solution is an inorganic compound used in organic synthesis and as a reducing agent.

  • Acrivastine

    Acrivastine is a short-acting histamine 1 receptor antagonist.